Proprietary CPT billing code further strengthens commercialization and reimbursement foundation for Prevencio's ...
The Cologuard Plus test demonstrated 95% sensitivity for colorectal cancer detection at 94% specificity, making it the most accurate noninvasive CRC screening test reported in studies to date Building ...
Note: specificity including non-advanced findings includes colonoscopy results that were negative for cancer or advanced precancer upon histopathological review; specificity including no findings ...
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the U.S. Food and Drug Administration (FDA) approved ...
Repositioning to better reach the elusive 45- to 50-year-old segment of potential colon cancer screening patients, Cologuard ads have replaced people singing a version of the Sinatra standard “My Way” ...
An ongoing theme among medical marketing is the increasingly common embrace of Spanish-language marketing by health brands. Considering there are more than 41 million Spanish speakers in the U.S., ...
Cologuard Plus, a new version of the Cologuard colorectal screening test, became available in 2025. The manufacturer says the upgraded test may be 30% more accurate than the original Cologuard. If you ...
Ten years after first collecting an FDA approval, it’s time for version number two. Exact Sciences has received an agency green light for Cologuard Plus, the next generation of its mainstay, at-home ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results